Learn / BLTE
NASDAQ: BLTE
Belite Bio (BLTE) stock, explained like you're 5
Belite Bio trades on the Nasdaq under the ticker BLTE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6.2 billion dollars.
- Ticker
- BLTE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 6.2 billion dollars
Is Belite Bio a small, medium or large cap company?
No. Belite Bio is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Belite Bio makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BLTE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Belite Bio Stock In Focus After Stargardt Drug Filings In Three Markets (Yahoo Finance)
- Belite Bio stock price target maintained at $245 by H.C. Wainwright (Investing.com)
- Stargardt, an inherited eye disease, could get its first approved treatment in three countries. (Stock Titan)
- What Belite Bio (BLTE)'s New Tinlarebant Filings Mean For Shareholders (Simply Wall Street)
- HC Wainwright & Co. reiterates Buy rating on Belite Bio, $245 price target (TradingView)
Follow BLTE in your daily brief
Each trading day at 5 PM ET we post what happened to Belite Bio and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BLTE
Questions about Belite Bio stock
What does Belite Bio do?
Belite Bio trades on the Nasdaq under the ticker BLTE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6.2 billion dollars.
What is the ticker symbol for Belite Bio?
Belite Bio trades under the ticker BLTE on the Nasdaq.
What is Belite Bio's market cap?
Belite Bio is a mid cap stock with a market cap of about 6.2 billion dollars.
How does Belite Bio make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BLTE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BLTE stock every day?
Add BLTE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.